NIFTY 50

Nothing to cheer about Sun Pharma's FY20 guidance, says Research Delta Advisor

Updated : May 29, 2019 01:00 PM IST

Mehta said Sudhir Valia stepping down from executive positions may not directly have any impact on the financial performance of the company
Sun Pharma's fourth-quarter earnings were largely in line with the market expectations and its earnings guidance for the fiscal year 2019-20 was neither great nor dismal

You May Also Like

Live TV